PBS Biotech: Funding, Investors & Team (Sep 2026)
PBS Biotech, Inc, produces the easiest to use and most technologically-advanced bioreactors for the pharmaceutical industry. Their single-use bioreactors have the smallest per liter volume footprints and are fully scalable for any stage of the cell culture process, from R&D to clinical to cGMP production. They provide efficient, cost-effective disposable systems and top-notch technical services to help their customers solve complex cell culture challenges.
PBS Biotech has raised $49.0M across 3 funding rounds on record, the most recent an undisclosed round of $17.0M announced in Jan 2025.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
PBS Biotech Company Profile and Key Stats
Latest funding round on record: Jan 2025.
PBS Biotech Funding Rounds
PBS Biotech raised $10.0M in an undisclosed round announced in Aug 2021.
1.4 years later, an undisclosed round of $22.0M was announced in Jan 2023.
2 years later, an undisclosed round of $17.0M was announced in Jan 2025.
PBS Biotech Founders and Leadership Team
Contact details for the PBS Biotech team: 1 of 2 have an email address on file.
Start 14-day free trial →PBS Biotech Funding Compared to Other Health Care Startups
PBS Biotech's latest round of $17.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PBS Biotech in Health Care and Camarillo
Companies Similar to PBS Biotech
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…
PBS Biotech Funding FAQs
What does PBS Biotech do?
PBS Biotech, Inc, produces the easiest to use and most technologically-advanced bioreactors for the pharmaceutical industry. Their single-use bioreactors have the smallest per liter volume footprints and are fully scalable for any stage of the cell culture process, from R&D to clinical to cGMP production. They provide efficient, cost-effective disposable systems and top-notch technical services to help their customers solve complex cell culture challenges.
How much funding has PBS Biotech raised?
PBS Biotech has raised $49.0M across 3 rounds on record. The most recent is an undisclosed round of $17.0M announced in Jan 2025.
When did PBS Biotech last raise funding?
PBS Biotech's most recent funding round on record is an undisclosed round of $17.0M, announced in Jan 2025.
Who founded PBS Biotech?
FundedIQ lists Brian Lee (Founder), Gregory Zeikus (Founder) at PBS Biotech.
Where is PBS Biotech headquartered?
PBS Biotech is based in Camarillo, California, United States.
How many employees does PBS Biotech have?
PBS Biotech is in the 11-50 employee band.
How does PBS Biotech's funding compare to other Health Care startups?
PBS Biotech's latest round of $17.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's PBS Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PBS Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.